IP Library Granted Patent US 9,696,302
Granted Patent B2
US 9,696,302 · App. 14/478,692 · Granted Jul 4, 2017

Methods for isolating a target analyte from a heterogeneous sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,696,302
App. No.
14/478,692
Granted
Jul 4, 2017
Kind
B2
Abstract

The invention generally relates to methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.

Claims (17)

1. A method for isolating pathogen from a heterogeneous sample, the method comprising:

providing a vessel that contains a heterogeneous sample comprising pathogen, the vessel being coupled to a fluidic device that comprises a channel and a magnet;

introducing to the sample in the vessel a cocktail comprising a plurality of magnetic particles, conjugated to antibodies that bind said pathogen, thereby forming a mixture comprising antibody-bound pathogen particles;

flowing the mixture from the vessel through a channel in the fluidic device such that said magnetic particles attach to said magnet; and

separating antibody-bound pathogen attached to said magnet from other components in the sample.

2. The method of claim 1 , further comprising the step of characterizing the pathogen.

3. The method of claim 2 , wherein said characterizing step comprises identifying the pathogen.

4. The method of claim 3 , wherein said identifying step is selected from sequencing nucleic acid derived from the pathogen and amplifying the nucleic acid.

5. The method of claim 1 , wherein the sample is a blood sample.

6. The method of claim 1 , wherein the particles are differentially labeled.

7. The method of claim 6 , wherein the particles comprise is an optical label.

8. The method of claim 7 , wherein the optical label is a fluorescent label.

9. The method of claim 1 , wherein the antibodies are monoclonal antibodies.

10. The method of claim 1 , wherein the antibodies are polyclonal antibodies.

11. The method of claim 1 , wherein the pathogen is gram positive bacteria.

12. The method of claim 1 , wherein the pathogen is gram negative bacteria.

13. The method of claim 1 , wherein the pathogen is a virus.

Assignments (4)
MERGER Recorded Dec 21, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 041154/0174 →
CHANGE OF NAME Recorded Dec 21, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 041154/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 041154/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: DRYGA, SERGEY A.; ESCH, VICTOR C.; CLARIZIA, LISA-JO ANN; ADAMS, EDDIE W.; UNG, THEARITH H.; SITDIKOV, RAVIL A.
To: NANOMR, INC.
Reel/Frame 037927/0770 →